Review of PCR e-Course 2020 Late-Breaking Clinical Trials.

Authors :: Medranda GA
Yerasi C
Case BC
Forrestal BJ
Chezar-Azerrad C
Wermers JP
Waksman R
Source :: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2021 Jun; Vol. 27, pp. 67-70. Date of Electronic Publication: 2020 Jul 23.
Publication Year :: 2021
Abstract: Competing Interests: Declaration of competing interest Ron Waksman – Advisory Board: Amgen, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, Pi-Cardia Ltd.; Consultant: Amgen, Biotronik, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, Pi-Cardia Ltd.; Grant Support: AstraZeneca, Biotronik, Boston Scientific, Chiesi; Speakers Bureau: AstraZeneca, Chiesi; Investor: MedAlliance. All other authors – None.

Subjects :: Cardiac Catheterization
Coronary Angiography
Coronary Stenosis
Fractional Flow Reserve, Myocardial
Humans
Polymerase Chain Reaction
Predictive Value of Tests
Severity of Illness Index
Clinical Trials as Topic

Language :: English
ISSN :: 1878-0938
Volume :: 27
Database :: MEDLINE
Journal :: Cardiovascular revascularization medicine : including molecular interventions
Publication Type :: Academic Journal
Accession number :: 32952078
Full Text :: https://doi.org/10.1016/j.carrev.2020.07.022